MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
MADISON, Wis., April 16, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed the elive™ ex vivo tumor profiling platform, announced a scientific ...
People in almost any business must write from time to time, whether they like it or not. But whatever the project — like a marketer’s blog post, a business leader’s executive summary or a developer’s ...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison-based cancer ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Madison-based cancer diagnostics ...
A phase 1 first-in-human study of the novel anti-LLT1 antibody (ZM008) alone and in combination with anti-PD1 antibody in patients with advanced solid tumors. Phase II basket study to evaluate the ...
MADISON, Wis.--(BUSINESS WIRE)--#AACR--Elephas Biosciences Corporation (Elephas), a live tumor imaging company developing novel cancer diagnostic solutions, announced today the acceptance of three ...
Premal H. Patel, MD, PhD, appointed Chief Medical Officer; Dr. Michael F. Giordano joins Scientific Advisory Board Cancer is a leading cause of death worldwide, with the number of patients projected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results